Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from ABBV

3 Stocks You Won't Regret Buying in December 2022

The Fed Chairman recently indicated a slower pace of rate increases. However, many analysts still believe the economy will face a mild recession next year. Therefore, it could be wise to invest in quality stocks with solid growth prospects, such as AbbVie (ABBV), Bristol-Myers Squibb (BMY), and Lifeway Foods (LWAY).…

StockNews.com

5 Stocks Investors Can Hold Onto Forever

Although the stock market remains highly volatile due to high inflation levels and the Fed’s aggressive monetary policy stance, analysts believe consumer prices will significantly decline in 2023. Moreover, the Fed also signaled slower rate hikes ahead. So, fundamentally strong stocks, AbbVie (ABBV), CSX Corporation (CSX), Waste Management (WM), Stellantis…

StockNews.com

3 Health Care Stocks That Are No-Brainer Buys Right Now

The healthcare industry is expected to witness significant growth in the foreseeable future, driven by rising health awareness, an aging population, and increasing chronic diseases worldwide. Furthermore, the healthcare industry is known to perform steadily regardless of economic conditions because of the inelastic demand for healthcare products and services. Therefore,…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

2 Strong Health Care Stocks to Add to Your Portfolio Now

The global healthcare industry is showing robust growth prospects with the growing adoption of advanced technologies, rising health awareness, and increasing chronic diseases. Amid rising spending on medicines, fundamentally strong healthcare stocks AbbVie (ABBV) and Bristol-Myers Squibb (BMY) might be ideal additions to your portfolio now. Read on.

StockNews.com

1 No-Brainer Stock to Buy That Could Help You Retire Earlier

Biopharma giant AbbVie (ABBV) is well-placed to gain from its drug pipeline, recent drug approvals, and strategic acquisitions. Given its strong fundamentals, discounted valuation, high profitability, reliable dividends, and favorable analyst estimates, investing in this stock could help you retire earlier. Read more.

StockNews.com

Hot Stocks to Buy? 3 Medical Stocks to Consider Now

The healthcare industry tends to withstand challenging macro conditions relatively well, as it enjoys inelastic demand for its products and services. And given the solid long-term prospects of the industry, it could be wise to load up fundamentally sound medical stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck (MRK)…

StockNews.com

Looking for Passive Income? Try This Monster Stock

Leading biopharmaceutical company AbbVie Inc. (ABBV) is well-positioned to benefit from its diversified portfolio, research breakthroughs, drug and therapy approvals, acquisitions, and partnerships. The company has been increasingly paying dividends, supported by its stable earnings stream. Therefore, investors looking for passive income amid uncertain market conditions could invest in this…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

AbbVie Unusual Options Activity For October 28

A whale with a lot of money to spend has taken a noticeably bearish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 13 strange trades.

Benzinga

This Is What Whales Are Betting On AbbVie

A whale with a lot of money to spend has taken a noticeably bearish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 13 strange trades.

Benzinga

4 Stocks to Help You Navigate a Bear Market

Amid sky-high inflation and consecutive big rate hikes, recessionary fears are looming. We believe fundamentally sound and stable dividend-paying stocks Walmart (WMT), AbbVie (ABBV), Coca-Cola Company (KO), and International Paper Company (IP) could be ideal investments to navigate a bear market. Read more.

StockNews.com

5 Stocks Investors Can Count on in a Bear Market

The stock market is expected to remain under pressure as the Fed continues its hawkish stance to fight inflation. Moreover, the International Monetary Fund has recently warned of elevated global financial stability risk. We think fundamentally solid stocks UnitedHealth Group (UNH), Walmart (WMT), AbbVie (ABBV), Coca-Cola Company (KO), and Dollar…

StockNews.com

3 Stocks to Buy Now and Never Sell

Raging inflation and the Fed’s continued rate hikes have kept the stock market under tremendous pressure. Healthcare stocks have always been considered safe haven amid market uncertainties, and we think fundamentally solid stocks AbbVie (ABBV), Pfizer (PFE), and McKesson Corporation (MCK) could be ideal buys for the long term. Read…

StockNews.com

How Far Will AbbVie's Humira Revenue Fall in 2023?

The world's best-selling drug begins losing patent protections next year. AbbVie's revenue could take years to recover.

The Street

3 Safe Stocks You'll Want to Have Exposure to in 2022

The Fed’s aggressive monetary policies are raising recession fears. Amid such an environment, we think investors could consider adding AbbVie (ABBV), Pfizer (PFE), and Coca-Cola (KO) to their portfolios for stable returns. Read on to learn more….

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Check Out What Whales Are Doing With ABBV

Someone with a lot of money to spend has taken a bearish stance on AbbVie (NYSE:ABBV). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

StockNews.com

5 Blue Chip Stocks to Help You Beat the Market Slump

Rising concerns over stubbornly-high inflation and the Fed’s commitment to bring it down to its desired level have kept equities under pressure lately. Amid increasing recessionary concerns, investing in blue-chip stocks such as Procter & Gamble (PG), AbbVie (ABBV), Pfizer (PFE), Dow (DOW), and Walgreens Boots Alliance (WBA) could help…

StockNews.com

4 Stocks to Buy With Market-Beating Potential

The stock market has been under pressure amid the high inflation and the Fed’s hawkish tilt. The Fed launched another 75 basis-point rate hike on Wednesday and indicated that it would keep increasing rates to bring down inflation to the target level. Thus, we think fundamentally solid stocks AbbVie (ABBV),…

StockNews.com

3 Stocks Bullish Traders Tend to Fall in Love With

The Fed’s continued monetary policy tightening and consequent recession fears are expected to keep the stock market under pressure in the upcoming months. However, bullish traders could keep paying with fundamentally strong stocks The Coca-Cola Company (KO), AbbVie (ABBV), and Merck & Co. (MRK). Read more….

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Safe Investments for Seniors to Consider Right Now

August CPI figures indicate that inflation is yet to be controlled, and the Fed might launch another significant interest rate hike next week. As recessionary fears loom over the economy, it might be ideal for seniors to invest in the fundamentally sound stocks Johnson & Johnson (JNJ), Coca-Cola (KO), and…

Benzinga

This Is What Whales Are Betting On AbbVie

Benzinga

What Are Whales Doing With AbbVie

A whale with a lot of money to spend has taken a noticeably bearish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 16 strange trades.

StockNews.com

3 Stocks to Buy Even in a Recession

Recession odds are rising due to the onslaught of aggressive rate hikes by the Fed. Healthcare is conventionally considered a defensive sector. Hence, we think Johnson & Johnson (JNJ), AbbVie (ABBV), and Bristol-Myers Squibb (BMY) might be solid buys now. Read on….

StockNews.com

It's Never Too Late to Get in on These 3 High-Quality Stocks

The stock market is expected to remain under immense pressure in the near term as the Federal Reserve hints at reiterating its stance of raising interest rates until inflation falls to the target level. Given an uncertain economic outlook, investors may want to make their portfolios sturdy by adding high-quality…

Benzinga

Looking At AbbVie's Recent Whale Trades

Someone with a lot of money to spend has taken a bullish stance on AbbVie (NYSE:ABBV). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

StockNews.com

3 Stocks With Decades of Dividend Payments

Concerns over high inflation, the Fed’s hawkish stance to control it, and an economic slowdown have led to immense stock market volatility. Therefore, it could be wise to invest in stocks with decades of dividend-paying history, such as Johnson & Johnson (JNJ), AbbVie (ABBV), and Becton, Dickinson and Company (BDX),…

1 … 4 5 6 7

People

Jerome Powell

2,772 stories

Dipanjan BanchurSince

722 stories

Kritika SarmahHer

712 stories

Mangeet Kaur BounsMangeet

595 stories

Santanu RoyHaving

215 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

International Monetary Fund

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.